Armata Pharmaceuticals (ARMP) EPS (Weighted Average and Diluted) (QoQ) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn |
| 10 | Armata Pharmaceuticals | 301.92 Mn | 297.17 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7.87% |
| Dec 31, 2025 | -363.51% |
| Sep 30, 2025 | -64.44% |
| Jun 30, 2025 | -125.00% |
| Mar 31, 2025 | 31.03% |
| Dec 31, 2024 | -93.33% |
| Sep 30, 2024 | 40.00% |
| Jun 30, 2024 | 63.77% |
| Mar 31, 2024 | -25.45% |
| Dec 31, 2023 | 36.05% |
| Sep 30, 2023 | -405.88% |
| Jun 30, 2023 | 57.50% |
| Mar 31, 2023 | -37.93% |
| Dec 31, 2022 | -20.83% |
| Sep 30, 2022 | 7.69% |
| Jun 30, 2022 | 13.33% |
| Mar 31, 2022 | -30.43% |
| Dec 31, 2021 | -4.55% |
| Sep 30, 2021 | 12.00% |
| Jun 30, 2021 | 7.41% |
| Mar 31, 2021 | 25.00% |
| Dec 31, 2020 | -16.13% |
| Sep 30, 2020 | -19.23% |
| Dec 31, 2019 | 39.73% |
| Sep 30, 2019 | -5.80% |
| Dec 31, 2018 | 60.00% |
| Sep 30, 2018 | 11.76% |
| Dec 31, 2017 | -293.80% |
| Sep 30, 2017 | 93.84% |
| Dec 31, 2016 | -115.17% |
| Sep 30, 2016 | 58.70% |
| Jun 30, 2016 | -853.66% |